The authors conducted a systematic review to assemble datasets that profile cell-type-specific molecular changes in early Alzheimer's disease (AD). They focused on publicly available human and rodent multiomic datasets that report alterations in neurons, microglia, astrocytes, and other brain cell types in early stages of AD. All source datasets are cited in the manuscript and supplementary material. The analysis is presented as a preprint and has not been peer reviewed.
To prioritise convergent signals across diverse experiments and molecular modalities, the study applied Meta-Analysis by Information Content (MAIC). MAIC is a computational framework that combines genomic data from heterogeneous experimental sources to identify consistent and high-information-content signals. The authors used MAIC to integrate multiomic findings across the assembled cell-type-specific datasets and thereby highlight shared pathways and cell-type-specific signatures relevant to early AD.
A principal outcome of the integrated analysis was the identification of electron transport chain dysfunction in mitochondria as a shared pathway across multiple brain cell types. Specifically, MAIC-ranked signals implicated disruptions in mitochondrial electron transport processes in neurons, microglia, and astrocytes. The study frames mitochondrial electron transport chain impairment as a convergent mechanistic feature detectable in early AD across distinct cellular compartments.
In addition to shared mitochondrial abnormalities, the integrated results revealed a pronounced astrocyte-specific signature relating to Wnt signalling. This pathway stood out in astrocyte-derived datasets, suggesting cell-type-restricted alterations in Wnt pathway components or regulation during early disease stages. The analysis therefore distinguishes between pathways that are broadly affected across cell types and those that appear more cell-type specific.
The study highlights several putative pathological neuro‑glial signalling interactions emerging from integrated data. Notable examples reported are APP-CD74, APOE-SORL1, and WNT-FZD/LRP6. These pairs are presented as candidate mechanisms by which neuronal and glial alterations may interact in early AD. The authors describe these as pathological neuro‑glial signalling mechanisms prioritised by the meta-analysis.
The integrated genomic signatures were cross-referenced with pharmacological data to identify therapeutics for potential repurposing. The authors note that the integration recovered therapeutics already under investigation in AD, including guanfacine, and also nominated compounds not previously prioritised for AD, such as eltrombopag and encorafenib. These agents are presented as candidates for further preclinical or translational evaluation rather than as validated therapies. No new clinical recommendations are made; the work aims to prioritise pathways and compounds for follow-up studies.
All data produced by the present work are reported to be contained in the manuscript and supplementary materials. The authors state that the analysis used only openly available human and rodent datasets, and that all dataset sources are cited (Table 1 in the manuscript). Ethical declarations include confirmation that relevant guidelines were followed and that necessary approvals or exemptions were obtained given the use of public data. The authors declare no competing interests. Because the report is a preprint, results have not been certified by peer review, and the authors caution that findings should not be used to guide clinical practice until validated.
Using a systematic review and multiomic integration with MAIC, the authors prioritised convergent pathways in early AD. The integration points to a broad mitochondrial electron transport chain dysfunction across neurons, microglia, and astrocytes, and to an astrocyte-specific alteration in Wnt signalling. Identified neuro‑glial signalling pairs and candidate repurposing drugs are proposed as priorities for further mechanistic and translational research. The study provides a resource and a ranked set of hypotheses for subsequent experimental validation, with full data and code links provided in the manuscript supplementary materials.